Defining and targeting cancer cell-intrinsic vulnerabilities in renal cell carcinoma
Active Project Grant Awarded Last action
- Award ID
- HT94252410836
- Recipient
-
The Royal Institution For The Advancement Of Learning UEI VJ62F6V2LE48
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $769,073
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 74% complete
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from USAspending.gov.
About this award
This $769,073 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research to define and target cancer cell-intrinsic vulnerabilities in renal cell carcinoma. The grant was awarded to the Royal Institution for the Advancement of Learning / McGill Office of Sponsored Research Division, a private university affiliated with McGill University in Montreal, Canada. The research will be conducted from August 1, 2024 through July 31, 2027 and aims to advance scientific understanding and therapeutic approaches for this form of kidney cancer. The award leverages the institution's expertise in areas such as neuroscience, genetics, and medicine to address critical healthcare challenges facing military service members and the broader public.
Quick answers
Who received award HT94252410836?
HT94252410836 was awarded to The Royal Institution For The Advancement Of Learning by Defense Health Agency (Department of Defense) on August 1, 2024.
How much is award HT94252410836 worth?
$769,073 has been obligated on HT94252410836.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award